Sentence examples for information expeditiously from inspiring English sources

A STEP development tool, ST-Developer, and Visual C++ were used to develop this module, which can be used to record key information expeditiously during a collaborative process, and can also be used for further exchange of information, or as the basis for manufacturability evaluation.

However, toxicology as a field contributes to its own failures to generate information expeditiously and to respond to controversies through its lack of systematic methods and evidence-based principles similar to those that have been successfully applied to resolve controversies and reach decisions in other fields related to public health.

The FGDs produced a large amount of key information relatively expeditiously and in a way that allowed the participation of consumers who were unwell and would not otherwise have the opportunity to have their voice heard.

If we do not establish a standards-based infrastructure expeditiously, however, health information systems will likely store increasing amounts of genomic data using idiosyncratic approaches, and efforts at providing widespread, effective CDS for genomic medicine will be severely hindered by the presence of entrenched information systems that lack interoperability.

"We are reviewing it and are happy to provide the information that he is seeking as expeditiously as we can," Ms. Daglian said.

Genomic data can now be obtained expeditiously and inexpensively.

"Staff is speaking with witnesses and reviewing documents and other information," she said, adding that investigators "are proceeding as expeditiously as they can".

Thus, how to utilize information technology to reduce work load for staff and expeditiously improve work efficiency and healthcare service quality is presently the top priority for every healthcare institution.

These experiments allow rapid screening of commercially available antiviral agents, enabling those with in vitro evidence of activity to move expeditiously into clinical studies, since safety and pharmacokinetic information in humans is already available for other disease indications.

The very nature of this format allows for more current data to be presented concisely and as expeditiously as possible.

Serious adverse events will be reported expeditiously to the sponsor, who in turn will inform the CI.